down-arrowleft-arrowright-arrow

Ralph E. Labaton Associate

Mr. Labaton’s diverse experience representing both plaintiffs and defendants in complex litigation matters provides his clients a unique, multi-dimensional perspective when responding to their needs.

LOCATION

New York

212-588-0800

745 Fifth Avenue, 10th Floor,
New York, NY 10151

VIEW IN MAPS

OVERVIEW

Ralph E. Labaton is an associate in the New York office of Haug Partners, where he focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment or “pay-for-delay” pharmaceutical actions. In addition to managing his active caseload, Mr. Labaton also advises clients seeking to obtain and protect intellectual property rights, such as patents and trademarks.

Prior to joining the firm, Mr. Labaton was an associate at a national litigation firm where he represented institutional investors, businesses, and consumers in complex antitrust, securities, and data privacy litigation. While in law school, Mr. Labaton worked as a legal intern for the U.S. Securities and Exchange Commission in the Division of Enforcement, and completed a fellowship with the Brooklyn Volunteer Lawyers Project.

Mr. Labaton earned his J.D. from Cornell Law School (2016) with a concentration in Business Law & Regulation, where he was the Vice President of the Mock Trial Board and a Co-Founder of The Louis D. Brandeis Center for Human Rights Under Law. Mr. Labaton also earned the CALI Award for Excellence for his efforts in the Securities Law Clinic, where he represented investors in FINRA arbitration proceedings. Mr. Labaton earned his B.B.A., cum laude, from Baruch College, Zicklin School of Business (2013).

Mr. Labaton also devotes his time to community efforts, including serving as a Member of the Young Professionals Committee of Friends of Jerusalem College of Technology.

  • Currently defending a major biopharmaceutical company in several “pay-for-delay” cases consolidated in the District of Massachusetts.
  • Currently defending major biopharmaceutical companies against alleged Walker Process patent fraud claims in the District of Delaware.
  • Currently advising startup company seeking to obtain patents and trademarks for a novel smartphone dating application.
  • Successfully overturned dismissal of federal and state wiretap and invasion of privacy claims against social media company for allegedly tracking users’ web browsing while logged off under a novel unjust enrichment theory.
  • Assisted in recovering an up to $500 million settlement (preliminary approval granted) for a nationwide class of smartphone owners who claimed that the defendant secretly throttled device performance.
  • Achieved substantial injunctive relief and financial benefit for a class of homeowners, fixing a website vulnerability prior to a data breach.
  • Recovered a $19.5 million settlement for investors in an energy and power company relating to the company’s claims regarding the value and growth prospects of its renewable energy segment.
  • David Shotlander and Ralph E. Labaton, “No FRANDS in Antitrust? Qualcomm’s Rejection of FRAND Violations as a Predicate to an Antitrust Violation” Haug Partners LLP, October 6, 2020, https://www.haugpartners.com/article/no-frands-in-antitrust-qualcomms-rejection-of-frand-violations-as-a-predicate-to-an-antitrust-violation/.
  • Laura Chubb and Ralph E. Labaton, “Ninth Circuit Reverses Northern District of California Decision in FTC v. Qualcomm Inc., No. 19-16122” Haug Partners LLP, August 13, 2020, https://www.haugpartners.com/article/ninth-circuit-reverses-northern-district-of-california-decision-in-ftc-v-qualcomm-inc-no-19-16122/.
  • Mike Brockmeyer, Fred Kelly, Josh Barlow, David Shotlander and Ralph E. Labaton, “Defendants Successfully Disqualify Bankrupt Wholesaler Rochester Drug Co-Operative From Representing Class of Purchasers in Intuniv Antitrust Litigation” Haug Partners LLP, July 9, 2020, https://www.haugpartners.com/article/defendants-successfully-disqualify-bankrupt-wholesaler-rochester-drug-co-operative-from-representing-class-of-purchasers-in-intuniv-antitrust-litigation/.
  • David Shotlander and Ralph E. Labaton, “FDA And FTC To Scrutinize Biologics Competition” Haug Partners LLP, February 6, 2020, https://www.haugpartners.com/article/fda-and-ftc-to-scrutinize-biologics-competition/.
  • Marquis Who’s Who in America, 2020-present
  • Cornell Law School, (J.D., 2016)
  • Baruch College, Zicklin School of Business (B.B.A., cum laude, 2013)
  • New York
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • Southern District of New York
  • Eastern District of New York
  • Federal Circuit Bar Association
  • Antitrust Counseling
  • Antitrust Government Investigation
  • Antitrust Litigation
  • Appellate Litigation
  • Biotechnology Litigation
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Products Litigation
  • Due Diligence & Investigations
  • Hatch-Waxman Litigation
  • Intellectual Property Litigation
  • Life Sciences Litigation
  • Trade Secret Litigation
  • Trademarks & Unfair Competition

212-588-0800
rlabaton@haugpartners.com

Related Services

  • Antitrust Counseling
  • Antitrust Government Investigation
  • Antitrust Litigation
  • Appellate Litigation
  • Biotechnology Litigation
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Products Litigation
  • Due Diligence & Investigations
  • Hatch-Waxman Litigation
  • Intellectual Property Litigation
  • Life Sciences Litigation
  • Trade Secret Litigation
  • Trademarks & Unfair Competition

BAR ADMISSIONS

  • New York
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • Southern District of New York
  • Eastern District of New York

Haug Partners LLP
745 Fifth Avenue, 10th Floor,
New York, NY 10151
212-588-0800
haugpartners.com

Ralph E. Labaton

Associate

HIGHLIGHT

Mr. Labaton’s diverse experience representing both plaintiffs and defendants in complex litigation matters provides his clients a unique, multi-dimensional perspective when responding to their needs.

OVERVIEW

Ralph E. Labaton is an associate in the New York office of Haug Partners, where he focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment or “pay-for-delay” pharmaceutical actions. In addition to managing his active caseload, Mr. Labaton also advises clients seeking to obtain and protect intellectual property rights, such as patents and trademarks.

Prior to joining the firm, Mr. Labaton was an associate at a national litigation firm where he represented institutional investors, businesses, and consumers in complex antitrust, securities, and data privacy litigation. While in law school, Mr. Labaton worked as a legal intern for the U.S. Securities and Exchange Commission in the Division of Enforcement, and completed a fellowship with the Brooklyn Volunteer Lawyers Project.

Mr. Labaton earned his J.D. from Cornell Law School (2016) with a concentration in Business Law & Regulation, where he was the Vice President of the Mock Trial Board and a Co-Founder of The Louis D. Brandeis Center for Human Rights Under Law. Mr. Labaton also earned the CALI Award for Excellence for his efforts in the Securities Law Clinic, where he represented investors in FINRA arbitration proceedings. Mr. Labaton earned his B.B.A., cum laude, from Baruch College, Zicklin School of Business (2013).

Mr. Labaton also devotes his time to community efforts, including serving as a Member of the Young Professionals Committee of Friends of Jerusalem College of Technology.

REPRESENTATIVE MATTERS

  • Currently defending a major biopharmaceutical company in several “pay-for-delay” cases consolidated in the District of Massachusetts.
  • Currently defending major biopharmaceutical companies against alleged Walker Process patent fraud claims in the District of Delaware.
  • Currently advising startup company seeking to obtain patents and trademarks for a novel smartphone dating application.
  • Successfully overturned dismissal of federal and state wiretap and invasion of privacy claims against social media company for allegedly tracking users’ web browsing while logged off under a novel unjust enrichment theory.
  • Assisted in recovering an up to $500 million settlement (preliminary approval granted) for a nationwide class of smartphone owners who claimed that the defendant secretly throttled device performance.
  • Achieved substantial injunctive relief and financial benefit for a class of homeowners, fixing a website vulnerability prior to a data breach.
  • Recovered a $19.5 million settlement for investors in an energy and power company relating to the company’s claims regarding the value and growth prospects of its renewable energy segment.

PUBLICATIONS

  • David Shotlander and Ralph E. Labaton, “No FRANDS in Antitrust? Qualcomm’s Rejection of FRAND Violations as a Predicate to an Antitrust Violation” Haug Partners LLP, October 6, 2020, https://www.haugpartners.com/article/no-frands-in-antitrust-qualcomms-rejection-of-frand-violations-as-a-predicate-to-an-antitrust-violation/.
  • Laura Chubb and Ralph E. Labaton, “Ninth Circuit Reverses Northern District of California Decision in FTC v. Qualcomm Inc., No. 19-16122” Haug Partners LLP, August 13, 2020, https://www.haugpartners.com/article/ninth-circuit-reverses-northern-district-of-california-decision-in-ftc-v-qualcomm-inc-no-19-16122/.
  • Mike Brockmeyer, Fred Kelly, Josh Barlow, David Shotlander and Ralph E. Labaton, “Defendants Successfully Disqualify Bankrupt Wholesaler Rochester Drug Co-Operative From Representing Class of Purchasers in Intuniv Antitrust Litigation” Haug Partners LLP, July 9, 2020, https://www.haugpartners.com/article/defendants-successfully-disqualify-bankrupt-wholesaler-rochester-drug-co-operative-from-representing-class-of-purchasers-in-intuniv-antitrust-litigation/.
  • David Shotlander and Ralph E. Labaton, “FDA And FTC To Scrutinize Biologics Competition” Haug Partners LLP, February 6, 2020, https://www.haugpartners.com/article/fda-and-ftc-to-scrutinize-biologics-competition/.

AWARDS

  • Marquis Who’s Who in America, 2020-present

EDUCATION

  • Cornell Law School, (J.D., 2016)
  • Baruch College, Zicklin School of Business (B.B.A., cum laude, 2013)

BAR ADMISSIONS

  • New York
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • Southern District of New York
  • Eastern District of New York

MEMBERSHIPS

  • Federal Circuit Bar Association

LANGUAGES

  • Hebrew